Bloudek, L. M., Makenbaeva, D., & Eaddy, M. (2015). Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors. Am Health Drug Benefits.
Chicago Style aipamenaBloudek, Lisa M., Dinara Makenbaeva, and Michael Eaddy. "Anticipated Impact of Generic Imatinib Market Entry On the Costs of Tyrosine Kinase Inhibitors." Am Health Drug Benefits 2015.
MLA aipamenaBloudek, Lisa M., Dinara Makenbaeva, and Michael Eaddy. "Anticipated Impact of Generic Imatinib Market Entry On the Costs of Tyrosine Kinase Inhibitors." Am Health Drug Benefits 2015.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.